{"public_id":"cl_d17c473b2e66ef49e11c931cc0864cec","status":"active","superseded_by_public_id":null,"corpus_id":11887083,"text":"11-dehydro-thromboxane B2, 2,3-dinor-thromboxane B2, and thymidine glycol showed significant increasing trends across the groups in urine.","confidence":0.96,"paper":{"corpus_id":11887083,"title":"A cross-sectional investigation of biomarkers of risk after a decade of smoking","url":"https://sah.borca.ai/papers/11887083"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_3898839508439a5f3bb63b07a22c6793","name":"2,3-dinor-thromboxane B2","description":"A urinary thromboxane metabolite measured as a potential cardiovascular risk biomarker.","types":["urinary biomarker"],"url":"https://sah.borca.ai/concepts/co_3898839508439a5f3bb63b07a22c6793"},{"public_id":"co_48c429c351f96dff379b925f086ba327","name":"thymidine glycol","description":"A urinary biomarker associated with oxidative DNA damage and measured in the study.","types":["urinary biomarker"],"url":"https://sah.borca.ai/concepts/co_48c429c351f96dff379b925f086ba327"},{"public_id":"co_5e70cc5d6267110ac39085aecbf2dee6","name":"11-dehydro-thromboxane B2","description":"A urinary thromboxane metabolite measured as a potential cardiovascular risk biomarker.","types":["urinary biomarker"],"url":"https://sah.borca.ai/concepts/co_5e70cc5d6267110ac39085aecbf2dee6"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_d17c473b2e66ef49e11c931cc0864cec"}